These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 36946344)
1. [Bioinformatic analysis of the clinical significance of calneuron 1 (CALN1) in glioma and its correlation with immune cell infiltration]. Zhang H; Zhang J; Wang T Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Mar; 39(3):205-212. PubMed ID: 36946344 [TBL] [Abstract][Full Text] [Related]
2. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry. Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924 [TBL] [Abstract][Full Text] [Related]
3. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma. Hao YP; Wang WY; Qiao Q; Li G Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884 [TBL] [Abstract][Full Text] [Related]
4. Ge X; Xu M; Cheng T; Hu N; Sun P; Lu B; Wang Z; Li J Front Immunol; 2022; 13():974346. PubMed ID: 36275718 [TBL] [Abstract][Full Text] [Related]
5. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients. Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941 [TBL] [Abstract][Full Text] [Related]
6. GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis. Liang K; Guo Z; Zhang S; Chen D; Zou R; Weng Y; Peng C; Xu Z; Zhang J; Liu X; Pang X; Ji Y; Liao D; Lai M; Peng H; Ke Y; Wang Z; Wang Y Aging (Albany NY); 2023 Oct; 15(19):10146-10167. PubMed ID: 37837549 [TBL] [Abstract][Full Text] [Related]
7. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data. Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666 [TBL] [Abstract][Full Text] [Related]
8. High Expression of CISD2 in Relation to Adverse Outcome and Abnormal Immune Cell Infiltration in Glioma. Zhang F; Cai HB; Liu HZ; Gao S; Wang B; Hu YC; Cheng HW; Liu JX; Gao Y; Hong WM Dis Markers; 2022; 2022():8133505. PubMed ID: 35493303 [TBL] [Abstract][Full Text] [Related]
9. Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma. Lv L; Zhang Y; Zhao Y; Wei Q; Zhao Y; Yi Q Front Cell Neurosci; 2021; 15():704344. PubMed ID: 34335194 [No Abstract] [Full Text] [Related]
10. CNPY4 is a potential promising prognostic-related biomarker and correlated with immune infiltrates in gliomas. Li JW; Huang QR; Mo LG Medicine (Baltimore); 2022 Aug; 101(33):e30044. PubMed ID: 35984129 [TBL] [Abstract][Full Text] [Related]
11. High TRAF3IP3 Level Predicts Poor Prognosis of Patients with Gliomas. Yang G; Tang S; Zhang J; Qin L World Neurosurg; 2021 Apr; 148():e436-e449. PubMed ID: 33444836 [TBL] [Abstract][Full Text] [Related]
12. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma. Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355 [TBL] [Abstract][Full Text] [Related]
13. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma. Zhang W; Li L; Bian PP; Luo QP; Xiong ZT Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030 [TBL] [Abstract][Full Text] [Related]
14. Qu S; Liu J; Wang H Front Immunol; 2021; 12():648416. PubMed ID: 33889156 [TBL] [Abstract][Full Text] [Related]
15. Calponin 3 Acts as a Potential Diagnostic and Prognostic Marker and Promotes Glioma Cell Proliferation, Migration, and Invasion. Xie Y; Ding W; Xiang Y; Wang X; Yang J World Neurosurg; 2022 Sep; 165():e721-e731. PubMed ID: 35792226 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma. Li Y; Zhang Y; Wu Z; Sun P BMC Neurol; 2023 Jan; 23(1):17. PubMed ID: 36639743 [TBL] [Abstract][Full Text] [Related]
17. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis. Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q Front Genet; 2022; 13():1053263. PubMed ID: 36712869 [No Abstract] [Full Text] [Related]
18. Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma. Chai RC; Wang N; Chang YZ; Zhang KN; Li JJ; Niu JJ; Wu F; Liu YQ; Wang YZ Cancer Cell Int; 2019; 19():155. PubMed ID: 31171919 [TBL] [Abstract][Full Text] [Related]
19. LGALS3 Is a Poor Prognostic Factor in Diffusely Infiltrating Gliomas and Is Closely Correlated With CD163+ Tumor-Associated Macrophages. Hu WM; Yang YZ; Zhang TZ; Qin CF; Li XN Front Med (Lausanne); 2020; 7():182. PubMed ID: 32528967 [No Abstract] [Full Text] [Related]
20. Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG). Liu H; Wang J; Luo T; Zhen Z; Liu L; Zheng Y; Zhang C; Hu X Front Endocrinol (Lausanne); 2022; 13():1106120. PubMed ID: 36714574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]